Completed PHASE4 INTERVENTIONAL 2-arm NCT02011750

Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii Infection in Early Course Schizophrenia

Pilot Trial of Valproate as Adjunctive Treatment for Toxoplasma Gondii

Sponsor: Mansoura University

Interventions Placebo Sodium Valproate treatment

Updated 7 times since 2017 Last updated: Feb 13, 2018 Started: Apr 1, 2013 Primary completion: Oct 30, 2017 Completion: Dec 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Schizophrenia and Toxoplasmosis, this trial is completed. The trial is conducted by Mansoura University and has accumulated 7 data snapshots since 2013. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4

▶ Show 2 earlier versions

Mar 2018 — Jun 2018 [monthly]

Completed PHASE4

Status: Active Not Recruiting → Completed
Jan 2017 — Mar 2018 [monthly]

Active Not Recruiting PHASE4

First recorded

Apr 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mansoura University
Stanley Medical Research Institute
University of Pittsburgh

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Al Mansurah, Egypt